We also observed that serum exosomal BCYRN1 expression was markedly reduced after the complete dissection of bladder tumors, and patients who exhibited reduced BCYRN1 expression showed no recurrence after surgery for more than 2 years. This evidence concerns the gene BCYRN1 and urinary bladder neoplasm.